Dekho, FY26 mein company ki revenue sirf ₹69.04 Lakhs rahi. Aur net loss toh double se bhi zyada ho gaya, jo FY25 ke ₹5.57 crore se badh kar ₹13.08 crore ho gaya. Q4 mein toh revenue mein toh aur bhi badi giraavat aayi, 69.90% kam ho kar sirf ₹67.49 Lakhs reh gayi.
Lekin jahan loss badha hai, wahi balance sheet mein ek bada positive change aaya hai. Company ka net worth negative ₹1.73 crore (FY25) se nikal kar ab ₹27.18 crore par pahunch gaya hai. Iska main reason hai Silvassa aur Bankura mein jo assets hain unki revaluation aur NCLT approved restructuring ke baad jo naya equity issue kiya gaya hai.
Asal mein, company filhaal NCLT ke supervision mein Corporate Insolvency Resolution Process (CIRP) se guzar rahi hai. Is plan ka ek bada hissa hai promoters dwara equity ke through naya paisa daalna, jisse company ki financial health sudharne ki koshish ho rahi hai.
Par real picture operations ki taraf dekhein toh situation alarming hai. Company ka annual expenses ₹4.86 crore hai, jo uske revenue ₹0.69 crore se kahin zyada hai! Yeh toh bahut bada gap hai. Aur agar subsidiary ki baat karein toh uske paas March 31, 2026 tak koi realizable value wale assets nahi the. Upar se, company ka debt bhi badh kar ₹18.46 crore ho gaya hai.
Ab investors ko kya dekhna chahiye? Sabse pehle toh NCLT plan ka successful completion. Phir yeh ki company apne core business mein koi turnaround laa paati hai ya nahi, aur revenue kaise badhegi. Management ko high operational costs, subsidiary ke issues aur badhte hue debt ko handle karna hoga.